 |
 |

COMMENTS AND OPINIONS
Are We Ignoring the Elephant in the Room?
Ayad Jindeel, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Cook et al1 reported no association between migraine and coronary heart disease (CHD) after a mean of 12 years of follow-up in the Physicians' Health Study (PHS). This study included information through March 2000. Kurth et al2 extended the follow-up period of the PHS participants to February 2005. They concluded that "migraine was associated with increased risk of major CVD [cardiovascular disease]"2(p795) and that "[t]he associations between migraine and major CVD, ischemic stroke, and MI [myocardial infarction] were not significantly modified by smoking and hypertension status or by randomized aspirin assignment."2(p797) The authors "had no information about the use of migraine-specific drugs (ie, triptans and ergot alkaloids)."2(p800) However, in a study by the same authors regarding the Women Health Study "women were asked on the 48-month questionnaire to provide information regarding medication use during the previous 2 weeks. The frequency of migraine-specific drug use among women who . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Migraine and Risk of Cardiovascular Disease in Men
Tobias Kurth, J. Michael Gaziano, Nancy R. Cook, Vadim Bubes, Giancarlo Logroscino, Hans-Christoph Diener, and Julie E. Buring
Arch Intern Med. 2007;167(8):795-801.
ABSTRACT
| FULL TEXT
|